UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q3 2021 Earnings Conference Call November 5, 2021 8:30 AM ET Company Participants Alexa Huerta - Senior Director of Investor Relations Jon Serbousek - President & Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call Participants Mathew Blackman - Stifel Anthony Petrone - Jefferies Jeffrey Cohen - Ladenburg Thalmann Jim Sidoti - Sidoti & Company David Turkaly - JMP Securities Operator Good day, and thank you for standing by. Welcome to the Orthofix Q ...

FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisd ...

Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2021 Earnings Conference Call August 6, 2021 8:30 AM ET Company Participants Alexa Huerta – Senior Director, Investor Relations Jon Serbousek – President and Chief Executive Officer Doug Rice – Chief Financial Officer Conference Call Participants Matthew Blackman – Stifel Anthony Petrone – Jefferies Jeffrey Cohen – Ladenburg and Thalmann Operator Good day and thank you for standing by. Welcome to the Orthofix Medical Inc Q2 2021 Earnings Call. At this time all partici ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Not applicable (Former name, former address and former fiscal year, if changed since last report) Indicate by check mark whether the registrant: (1) has fil ...

The New SeaSpine Accelerating the Pace of Innovation & Design May 2021 § SeaSpine ©2021 SeaSpine Orthopedics Corporation. All rights reserved. 1 Forward-looking Statements & Disclaimer This presentation includes statements that may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "estimate," "expect," "anticipate," "project," "forecast" and similar expressions, or the negative thereof, among others, generally identify forward-look ...

SeaSpine Holdings Corporation (SPNE) Q1 2021 Earnings Conference Call May 3, 2021 4:30 PM ET Company Participants Leigh Salvo - IR Keith Valentine - CEO John Bostjancic - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Ryan Zimmerman - BTIG Kyle Rose - Canaccord Mathew Blackman - Stifel Samuel Brodovsky - Truist Brandon Folkes - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Thalmann Operator Welcome to SeaSpine's 2021 First Quarter Financial Results Conference Call. [Operator Instructions] As ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark one) Commission File Number: 0-19961 ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 98-1340767 (State or other jurisdiction of incorporation or organization) 3451 Plano Parkway, Lewisville, Texas 75056 (Address of principal executive offices) (Zip Code) (214) 937-2000 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period end ...

SeaSpine Holdings Corporation (SPNE) Q4 2020 Results Conference Call March 1, 2021 4:30 PM ET Company Participants Keith Valentine - CEO John Bostjancic - CFO Conference Call Participants Kyle Rose - Canaccord Ryan Zimmerman - BTIG Kaila Krum - Truist Mathew Blackman - Stifel Jeffrey Cohen - Ladenburg Thalmann Brandon Folkes - Cantor Fitzgerald Operator Thank you for standing by and welcome to the Quarter Four, 2020 SeaSpine Holdings Corporation Earnings Conference Call. At this time, all participants are i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ORTHOFIX MEDICAL INC. FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-19961 (214) 937-2000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) o ...